Eragny-sur-Oise, France, April 27, 2018 at 7:30am CEST – SAFE ORTHOPAEDICS (FR0012452746 – SAFOR), a company specialized in the design and marketing of single-use implants and instruments improving the minimally invasive treatment of spinal fracture conditions, is today reporting its full-year 2017 results and its Q1 2018 revenues.
Safe Orthopaedics’ 2017 annual financial report will be available in the Investors > Documentation > Documents and Publications section of the Company’s website (www.SafeOrtho.com) from April 27,2018.
“Safe Orthopaedics reached a turning point in 2017. As well as significantly strengthening our sales team and giving it a strategic focus on vertebral fractures, we achieved a clear improvement in our financial performance, including our best-ever year-on-year growth rate of 37%1”, commented Pierre Dumouchel, Chief Executive Officer and Co-founder of Safe Orthopaedics. “2018 has got off to a healthy start, with surgical kit sales breaking above the 10,000 mark and revenues advancing by 22% in the first quarter. Given our consistent performances in France and the recent contribution to our international growth from Germany–two countries with a direct sales force—we are actively working to acquire a direct sales force in the United Kingdom and to develop new drivers of technological growth.”
Key upcoming dates in the financial calendar
- General Shareholders’ Meeting, Thursday June 28, 2018
- Second-quarter 2018 revenues: July 10, 2018 (after close)
[1] Revenues adjusted for operations discontinued in the United States since March 1, 2016
About Safe Orthopaedics
Founded in 2010, Safe Orthopaedics is a French medical technology company that offers the safest technologies to treat spinal fracture. Delivered sterile, all implants and respective disposable instrumentation are available to the surgeon at any time, any place. These technologies enable minimally invasive approaches, reducing risks of cross contamination and infection in the interest of the patient. Protected by 17 patent families, the SteriSpine™ Kits are CE marked and FDA cleared. The company is based at Eragny-Sur-Oise (France), and has 36 employees.
For more information, visit: www.SafeOrtho.com